Craig Wheeler - Apr 17, 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Craig Wheeler
Stock symbol
APLS
Transactions as of
Apr 17, 2025
Transactions value $
$513,149
Form type
4
Date filed
4/21/2025, 04:23 PM
Previous filing
Jun 7, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +16.5K $0.00 16.5K Apr 17, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Award $513K +28.2K $18.20 28.2K Apr 17, 2025 Common Stock 28.2K $18.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock unit was granted on April 17, 2025. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as adirector at his election.
F2 This represents a stock option award granted April 17, 2025 that vest 1/3rd per year over a three-year period subject to continued service.